BioCorRx Inc. (BICX) Financial Statements (2025 and earlier)

Company Profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 69865922,646280
Cash and cash equivalent 69865922,646280
Receivables 1     
Prepaid expense45838515721331
Other undisclosed current assets 141166582251878
Total current assets:1873172289753,047319
Noncurrent Assets
Operating lease, right-of-use asset97270385490459
Property, plant and equipment517710312914844
Long-term investments and receivables  4545454213
Long-term investments  4545454213
Intangible assets, net (including goodwill)910111771415
Intangible assets, net (excluding goodwill)910111771415
Deferred costs  48    
Other undisclosed noncurrent assets45 4813224236
Total noncurrent assets:202450592852887309
TOTAL ASSETS:3897678201,8273,933628
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,6493,9083,1892,4902,0271,555
Interest and dividends payable1,1541,1381,138898
Accounts payable2,4732,0131,7771,181709656
Accrued liabilities1,2681,207    
Other undisclosed accounts payable and accrued liabilities9076882581711800
Deferred revenue  333563135
Debt607298221 (55)673
Accrued reclamation costs 43     
Due to related parties991  39132
Other undisclosed current liabilities1,132134941499533,868
Total current liabilities:6,4315,3644,3863,0522,5516,127
Noncurrent Liabilities
Long-term debt and lease obligation  74 435428 
Long-term debt, excluding current maturities  74    
Liabilities, other than long-term debt, including:151853772103208
Deferred revenue 443772103
Operating lease, liability11181 435428
Other undisclosed liabilities, other than long-term debt      208
Other undisclosed noncurrent liabilities3,8953,3453,3582,4771,910 
Total noncurrent liabilities:3,9103,6053,3952,9852,441208
Total liabilities:10,3418,9687,7816,0374,9926,335
Equity
Equity, attributable to parent, including:(9,824)(8,202)(6,844)(4,210)(1,059)(5,706)
Preferred stock      16
Common stock987553
Common stock, value, subscriptions100100100100100100
Additional paid in capital68,14966,13062,99560,46660,11149,418
Accumulated deficit(78,103)(74,336)(69,967)(64,688)(61,216)(55,176)
Other undisclosed equity, attributable to parent22(104)22(94)(60)(67)
Equity, attributable to noncontrolling interest(129) (118)(115)(81) 
Other undisclosed equity    23116272
Total equity:(9,953)(8,202)(6,961)(4,095)(978)(5,634)
Other undisclosed liabilities and equity    (115)(81)(72)
TOTAL LIABILITIES AND EQUITY:3897678201,8273,933628

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues8921448123240377
Other income 139    
Cost of revenue(36)(19)(6)(96)(82)(171)
Cost of product and service sold  (19)    
Gross profit:531954227159206
Operating expenses(3,877)(4,912)(5,558)(7,615)(5,802)(5,003)
Other undisclosed operating income361969682171
Operating loss:(3,788)(4,698)(5,510)(7,492)(5,561)(4,626)
Nonoperating income (expense)173212993,985(487)(1,958)
Other nonoperating income5321    
Interest and debt expense(34)133(28)(26)(8)1
Loss from continuing operations before equity method investments, income taxes:(3,805)(4,243)(5,239)(3,533)(6,056)(6,584)
Other undisclosed income (loss) from continuing operations before income taxes34(133)    
Loss from continuing operations before income taxes:(3,770)(4,377)(5,239)(3,533)(6,056)(6,584)
Income tax expense    (66)  
Other undisclosed income from continuing operations    3,632  
Income (loss) from continuing operations:(3,770)(4,377)(5,239)34(6,056)(6,584)
Income (loss) before gain (loss) on sale of properties:(5,239)34(6,056)(6,584)
Other undisclosed net income  8,754    
Net income (loss):(3,770)4,377(5,239)34(6,056)(6,584)
Net income attributable to noncontrolling interest   5,2783,4726,0406,512
Other undisclosed net loss attributable to parent  (8,754)(5,250)(7,013)(6,032)(6,513)
Net loss attributable to parent:(3,770)(4,377)(5,211)(3,507)(6,048)(6,584)
Preferred stock dividends and other adjustments   70   
Other undisclosed net income available to common stockholders, basic      
Net loss available to common stockholders, diluted:(3,770)(4,377)(5,141)(3,507)(6,048)(6,584)

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(3,770)4,377(5,239)34(6,056)(6,584)
Comprehensive income (loss):(3,770)4,377(5,239)34(6,056)(6,584)
Comprehensive income, net of tax, attributable to noncontrolling interest   5,2783,4726,0406,512
Comprehensive income (loss), net of tax, attributable to parent:(3,770)4,377403,507(17)(72)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: